These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. [Use of azithromycin in the treatment of acute otitis media and tonsillopharyngitis: summary and conclusions. Klein JO; Schaad UB Pediatr Infect Dis J; 2004 Feb; 23(2 Suppl):S140-1. PubMed ID: 14770078 [No Abstract] [Full Text] [Related]
5. Changes in macrolide resistance among respiratory pathogens after decreased erythromycin consumption in Taiwan. Hsueh PR; Shyr JM; Wu JJ Clin Microbiol Infect; 2006 Mar; 12(3):296-8. PubMed ID: 16451421 [TBL] [Abstract][Full Text] [Related]
7. [Antimicrobial susceptibility of community-acquired respiratory tract pathogens isolated from patients in primary hospitals in Shanghai from 2007 to 2010]. Zhou CM; Hu BJ; Gao XD; Bao R; Xie HM; Huang SL; Tao LL; He LX Zhonghua Jie He He Hu Xi Za Zhi; 2013 May; 36(5):346-50. PubMed ID: 24047808 [TBL] [Abstract][Full Text] [Related]
8. The efficacy of cefditoren pivoxil in the treatment of lower respiratory tract infections, with a focus on the per-pathogen bacteriologic response in infections caused by Streptococcus pneumoniae and Haemophilus influenzae: a pooled analysis of seven clinical trials. Granizo JJ; Giménez MJ; Barberán J; Coronel P; Gimeno M; Aguilar L Clin Ther; 2006 Dec; 28(12):2061-9. PubMed ID: 17296462 [TBL] [Abstract][Full Text] [Related]
9. Evaluation of coamoxiclav and other antibiotics against S pneumoniae and H influenae from paediatric cases of acute respiratory infections. Krishnan P; Rajendran P; Sambandan AP; Anitha C; Chavda RK; Khobragade KJ J Indian Med Assoc; 2011 Apr; 109(4):241-2, 244. PubMed ID: 22187795 [TBL] [Abstract][Full Text] [Related]
10. Macrolide resistance in Streptococci and Haemophilus influenzae. Bozdogan B; Appelbaum PC Clin Lab Med; 2004 Jun; 24(2):455-75. PubMed ID: 15177849 [TBL] [Abstract][Full Text] [Related]
11. Formulation design and pharmaceutical development of a novel controlled release form of azithromycin for single-dose therapy. Lo JB; Appel LE; Herbig SM; McCray SB; Thombre AG Drug Dev Ind Pharm; 2009 Dec; 35(12):1522-9. PubMed ID: 19929212 [TBL] [Abstract][Full Text] [Related]
12. Contradiction between in vitro and clinical outcome: intravenous followed by oral azithromycin therapy demonstrated clinical efficacy in macrolide-resistant pneumococcal pneumonia. Kohno S; Tateda K; Kadota J; Fujita J; Niki Y; Watanabe A; Nagashima M J Infect Chemother; 2014 Mar; 20(3):199-207. PubMed ID: 24477328 [TBL] [Abstract][Full Text] [Related]
13. [The postantibiotic effect of azithromycin on respiratory pathogens]. Diculencu D; Andrews JM; Boswell FJ; Wise R Rev Med Chir Soc Med Nat Iasi; 1996; 100(3-4):128-34. PubMed ID: 9455450 [TBL] [Abstract][Full Text] [Related]
14. Properties of azithromycin that enhance the potential for compliance in children with upper respiratory tract infections. Powers JL Pediatr Infect Dis J; 1996 Sep; 15(9 Suppl):S30-7. PubMed ID: 8878244 [TBL] [Abstract][Full Text] [Related]
15. Susceptibility of Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis to 17 oral antimicrobial agents based on pharmacodynamic parameters: 1998-2001 U S Surveillance Study. Jacobs MR; Bajaksouzian S; Windau A; Good CE; Lin G; Pankuch GA; Appelbaum PC Clin Lab Med; 2004 Jun; 24(2):503-30. PubMed ID: 15177851 [TBL] [Abstract][Full Text] [Related]
16. Aerosol-based efficient delivery of azithromycin to alveolar macrophages for treatment of respiratory infections. Togami K; Chono S; Morimoto K Pharm Dev Technol; 2013; 18(6):1361-5. PubMed ID: 22812381 [TBL] [Abstract][Full Text] [Related]
17. Efficacy and safety of a novel, single-dose azithromycin microsphere formulation versus 10 days of levofloxacin for the treatment of acute bacterial sinusitis in adults. Murray JJ; Emparanza P; Lesinskas E; Tawadrous M; Breen JD Otolaryngol Head Neck Surg; 2005 Aug; 133(2):194-200. PubMed ID: 16087013 [TBL] [Abstract][Full Text] [Related]